Officer and Director Files Intent to Sell $1.1M in Stock Amidst Ongoing Sales
TWST has more than doubled off its 52-week low of $23.3.
Summary
An Officer and Director of Twist Bioscience Corp has filed an intent to sell $1.12 million in company stock, continuing a pattern of significant insider sales.
Key Events · Ownership and Investor Activity · TWST
-
Officer Files Intent to Sell
Emily M. Leproust, an Officer and Director, intends to sell 16,470 shares of common stock, valued at approximately $1.12 million.
-
Continuation of Insider Selling Pattern
This filing adds to a series of sales by Ms. Leproust, who has already sold approximately $3.23 million in shares over the past three months, bringing her total executed and intended sales to over $4.3 million.
-
Stock Trading Near 52-Week High
The proposed sale occurs while the company's stock is trading near its 52-week high of $69.20, potentially indicating a move to realize gains.
Analysis · TWST · Life Sciences
Emily M. Leproust, an Officer and Director, has filed a Form 144 indicating an intent to sell an additional $1.12 million worth of company stock. This follows a pattern of significant sales by the same executive, who has already sold approximately $3.23 million in shares over the past three months. The stock is currently trading near its 52-week high, which may motivate executives to lock in gains. This ongoing distribution by a key insider could be perceived negatively by investors.
How filings like this one have moved
In the 30 days to Nov 1, 2026, 32.5% of the 1962 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, TWST was trading at $69.03 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.3B. The 52-week trading range was $23.30 to $69.20. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.